Safety outcomes of Selective Serotonin Reuptake Inhibitors in Adolescent Attention-Deficit/Hyperactivity Disorder (The ASSURE study)

07/01/2022
02/04/2024
EU PAS number:
EUPAS44893
Study
Planned
Documents
Study protocol
Initial protocol
English (374.48 KB - PDF) View document
Study results
Study report
Other information